RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP

Regen BioPharma Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026

$0.00+0.00 (+50.00%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q4 FY2024 Ended Sep 30, 2024	Nov 29, 2024	Before market open	–	–	–

Announcements Regen BioPharma filed with the SEC

Parsed from the XBRL in Regen BioPharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Feb 10, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RGBP.

Advertisement
300 × 250